Surgical wounds are common
injuries of skin and tissues and usually become a clinical problem. Until now, various synthetic and natural
peptides have been widely explored as potential
drug candidates for wound healing. Inhibition of the TNF-α signaling pathway and promotion of angiogenesis are suggested to be involved in their effects. Angiogenesis at the
wound site is one of the essential requisites for rapid healing. In the present study, a novel
peptide extract derived from the natural source Lates calcarifer, commonly known as sea bass or barramundi, was evaluated for its wound healing property. The specific acidic and enzymatic approaches were employed for producing sea bass extract containing small size
peptides (molecular weight ranging from 1 kD to 5 kD). The cytotoxicity of the extract was examined in HaCaT and NIH3T3. After this, the effects of
enzyme digested
peptide extracts of sea bass on wound healing in mice were investigated. The
peptide extracts (660 and 1320 mg/kg/day) and control
protein (1320 mg/kg/day) was orally given to the wounded mice, respectively, for 12 days. The surgical method was improved by implanting a
silicone ring at the
wound site. The ring avoided the contracting effect in murine
wounds, making it more closely related to a clinical condition. The results showed promising improvement at the
wound site in mice. Sea bass
peptide extracts accelerated the wound healing process and enhanced the microvessel formation at the
wound site. The remarkable effects of this novel sea bass
peptide extract in healing traumatic
injuries revealed a new option for developing
wound management.